Application of NanoString Technologies in Chronic Myeloid Leukemia, Essential Thrombocythemia, Primary Myelofibrosis, and Polycythemia Vera: A Pilot Study. [PDF]
Bae JH, Bae KJ, Cho CH.
europepmc +1 more source
A paradigm shift in the treatment of patients with polycythemia vera. The initial early use of recombinant interferon-alpha. [PDF]
Silver RT, Hasselbalch HC.
europepmc +1 more source
Conflating polycythemia vera with essential thrombocytosis. [PDF]
Spivak JL.
europepmc +1 more source
Different Colours of Polycythemia Vera: A Case Series. [PDF]
Viswanathan N, Adalarasan S, T S, S Y.
europepmc +1 more source
Neutrophil-to-lymphocyte ratio half reduction as a surrogate of molecular response in polycythemia vera treated with ropeginterferon alfa-2b. [PDF]
Yoon SY +14 more
europepmc +1 more source
Toward new therapy end points in polycythemia vera: targeting clonal and inflammatory pathways. [PDF]
Barbui T, Scandura JM.
europepmc +1 more source
OCT angiography in polycythemia vera. [PDF]
Panigrahi PK.
europepmc +1 more source
Consensus on the use of ropeginterferon alfa-2b in Japanese patients with polycythemia vera: a modified Delphi survey. [PDF]
Shimoda K +5 more
europepmc +1 more source
Synchronous Primary Hyperparathyroidism and Polycythemia Vera: A Case Report and Literature Review. [PDF]
Montazeri M +3 more
europepmc +1 more source

